Company intelligence / Profile preview
Mitos Pharmaceuticals, Inc.
Not specified, California*, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Mitos Pharmaceuticals, Inc. is a private pharmaceutical company based in California focused on developing small molecule therapeutics. Its lead candidate is Tempol, which targets hypoxia-inducible factor pathways and reactive oxygen species. The most advanced clinical program has reached Phase III for radiodermatitis and previously targeted alopecia in Phase II trials. There are two clinical trials associated with the company; one for prevention of alopecia induced by whole brain radiotherapy had an unknown status as of early 2025.
- Therapeutic areas
- Dermatology
- Modalities
- Small molecules (e.g., Tempol)
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Mitos Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mitos Pharmaceuticals, Inc..